HIGHFDA DRUG

Cipla Recalls Phytonadione Injectable Emulsion Due to Stability Issues

Cipla USA recalled 4,438 cartons of Phytonadione Injectable Emulsion on October 31, 2025. The product failed stability specifications, raising concerns about its safety. Consumers and healthcare providers must stop using the product immediately and seek guidance.

Official notice
PHYTONADIONECipla USA Inc.Health & Personal CareDrugs & MedicationsBatch # PH0072404APH0082404AExp. Date December 31

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
October 31, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
October 31, 2025
Hazard Level
HIGH
Brands
PHYTONADIONE, Cipla USA Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
PHYTONADIONE, Cipla USA Inc.
Product type
Injectable Emulsion
Model numbers
Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025
UPC codes
69097-708, 69097-709, 69097-709-96, 69097-708-96, 69097-708-31
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 31, 2025

  2. Reported by FDA DRUG

    December 10, 2025

  3. RecallRadar source check

    December 17, 2025

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Stability Specifications: Observed OOS results: eg results for colour index

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cipla Limited or your healthcare provider for guidance

About This Product

Phytonadione Injectable Emulsion is a medication used to treat vitamin K deficiency and support patients on anticoagulants. It is typically administered in clinical settings.

Why This Is Dangerous

The product's failure in stability specifications means it may not perform as intended, potentially leading to ineffective treatment.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers must cease use of the product immediately to avoid health risks. The recall could lead to disruption in treatment for individuals relying on vitamin K supplementation.

Practical Guidance

How to identify if yours is affected

  1. Locate the batch number on the vial or carton.
  2. Check if it matches Batch # PH0072404A or PH0082404A.
  3. Ensure the expiration date is December 31, 2025.

Where to find product info

Batch numbers and expiration dates can be found on the vial label or carton packaging.

What timeline to expect

Expect a refund or replacement processing time of approximately 4-6 weeks.

If the manufacturer is unresponsive

  • Document your correspondence with the company.
  • Reach out to the FDA if you do not receive a response.
  • Consider contacting a consumer protection agency if issues persist.

How to prevent similar issues

  • Always check for recalls on medications before use.
  • Consult healthcare providers regarding any concerns with medications.
  • Be aware of stability specifications when using injectable products.

Documentation advice

Keep records of your purchase, including receipts and any communications with the manufacturer or retailer.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

This recall involves Phytonadione Injectable Emulsion, USP 10mg/mL, in 10x1 mL single-dose vials. The vials have NDC# 69097-708-31, and the cartons have NDC 69097-708-96. This product was manufactured by Cipla Ltd. in India for Cipla USA, Inc. and has a lot number PH0072404A.

Key Facts

  • Recall date: October 31, 2025
  • Quantity recalled: 4,438 cartons
  • Manufactured in India
  • Rx only product

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Batch # PH0072404A
PH0082404A
Exp. Date December 31
2025
UPC Codes
69097-708
69097-709
69097-709-96
+2 more
Affected States
ALL
Report Date
December 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Cipla USA Recalls Lanthanum Carbonate Tablets Over Stability Issues

Cipla USA recalled 1,180 boxes of Lanthanum Carbonate chewable tablets on October 24, 2025. The recall follows a failure to meet stability specifications for hardness tests. Consumers and healthcare providers must stop using the product immediately.

LANTHANUM CARBONATE
Failed stability
Read more